Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Equipe Genetique des Anomalies du Developpement, |
RCV001027678 | SCV001190241 | likely pathogenic | Spinocerebellar ataxia type 19/22 | 2019-05-15 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV001027678 | SCV002604963 | likely pathogenic | Spinocerebellar ataxia type 19/22 | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003307800 | SCV004000976 | uncertain significance | Cardiovascular phenotype | 2023-03-24 | criteria provided, single submitter | clinical testing | The p.S357L variant (also known as c.1070C>T), located in coding exon 1 of the KCND3 gene, results from a C to T substitution at nucleotide position 1070. The serine at codon 357 is replaced by leucine, an amino acid with dissimilar properties. This variant has been detected in an individual reported to have cerebellar ataxia (Thomas Q et al. J Med Genet, 2022 May;59:445-452). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |